Risk Evaluation of Multiple Sclerosis Medications

June 25, 2016 /
Multiple Sclerosis


                                                                  

  


Click here to receive MS news via e-mail








Published on Jun 3, 2016
Dr. Daniel Kantor talks with Dr. Clyde Markowitz, Associate Professor of Neurology and Director of the MS Center at the Perelman School of Medicine at the University of Pennsylvania, about risk evaluation of Multiple Sclerosis medications.
===================================================
Dr. Markowitz – tells it like it is — 
     Stu’s Views : I enjoyed listening to the questions and the responses










     an MS World presentation

.






MS Views and News
Providing educational information, resources and services for those affected by MS

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews

Stay informed with MS news and information - Sign-up here

For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT


Share:

Categories

Latest Blog Posts